Navigation Links
Electric Field Therapy to Zap Cancerous Tumours

Boffins have made a new device, Novo-TTF (Tumor-Treating Fields), for treating brain cancer patients using electrical field therapy, which could more than double the survival rates for people with one of the most common types of brain tumour.

The device uses low intensity electrical fields delivered via insulated electrodes on the scalp, to disrupt tumour growth by interfering with cell division of cancerous cells which causes the cells to stop proliferating and die off instead of dividing and growing.

The device was developed by a team of researchers led by Professor Yoram Palti at the Technion-Israel Institute of Technology.

The fields disrupt the movement of a cell's inner building blocks during division, so that it dies off before proliferating. Cancer cells typically divide at a much faster rate than most normal cells, making them a prime target for TTF.

Treatments such as chemotherapy and radiation also target rapidly dividing cells, but they can cause severe side effects by damaging the intestinal lining and bone marrow, where normal cells divide quickly.

"One of the advantages of TTF therapy is that only a small fraction of its electrical fields can penetrate into these sensitive tissues," Palti said.

Researchers conducted a pilot study of 10 patients with recurrent glioblastoma, a rapidly growing type of brain tumour, to test the effectiveness of the treatment.

The researchers use specific alternating electric fields, called Tumor-Treating Fields (TTF) that home in on the unusual geometry of dividing cells.

The study found that the therapy significantly slowed the growth of tumours as well as increased survival rates. Previously, patients with advanced glioblastomas could expect to live on average six months or less. With the therapy, the average reprieve was more than a year, and three of patients in the small trial were still alive, more th an two years after their therapy began.

The positive results of the study were so encouraging that the U.S. Food and Drug Administration has allowed the researchers to skip Phase II and move directly to a Phase III clinical trial of the therapy, which will test the treatment in a larger group of patients.

The researchers have tested the treatment successfully on 15 types of cancer cells, including human breast, lung and skin cancer cells so far and are hoping that the therapy might be useful in treating a variety of cancers.

"Our basic assumption is that the treatment will be effective for most types of solid tumours," Palti said.

The findings of the study were published in the June issue of the Proceedings of the National Academy of Sciences USA.


'"/>




Related medicine news :

1. Researchers Develop An Electric Device For Relief From Migraine
2. Electrical Activity Alters Language Used By Nerve Cells
3. Unique Electrical Stimulation Device to Restore Mobility in Stroke Survivors
4. Amorous African Fish Exchange Electric Pulses While Mating
5. Scientists Destroy Cancer Cells Using Electric Pulses
6. Hazards of Electromagnetic Fields for children
7. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
8. Oman and Turkey To Cooperate in Health Field
9. New Rule Results In The Complete Makeover In The Field Of Drug Advertising
10. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
11. HIV Vaccine Field Trials In Advanced Stage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology: